Tumor organoid culture

Tumor organoid culture and screening and application of small molecule antitumor drugs in patients with malignant pleural effusion

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054496

Enrollment

Unknown

Registered

2021-12-18

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant pleural effusion

Interventions

Case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a definitive diagnosis of malignant pleural effusion.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The volume of tumor tissue;	—

Countries

China

Contacts

Public ContactShi Huanzhong

Beijing Chaoyang Hospital

yifengshuang@ccmu.edu.cn+86 10 85231483

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026